Telix Pharmaceuticals Limited (ASX:TLX) Changes Reporting Currency to USD
Reporting Currency Change
Telix Pharmaceuticals Limited has announced that effective 1 January 2025, it will change its reporting currency from Australian dollars to United States dollars (USD) in accordance with Australian Accounting Standards Board Standard 108. This change aligns the company’s financial reporting with the predominant currency used for its revenue, costs, and cash flows, which are primarily generated in the United States and denominated in USD.
Financial Reporting Impact
As a result, Telix’s 2025 half-year and annual financial results will be presented in USD. For comparative purposes, the company’s reviewed or audited restated historical information will be included in the half-year report for the six months ending 30 June 2025 and in the Annual Report for the year ending 31 December 2025.
Motley Fool contributor Lianne Eastty has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.